Browse studies
Find your next paid study
26 recruiting studies matching your filters
Phase 2
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SPN-821 as an Adjunctive Therapy in Adults With Major Depressive Disorder
This study will evaluate the efficacy and safety of SPN-821 in adults with major depressive disorder
Major Depressive Disorder (MDD)
Estimated
~$10 – $8,750
Supernus Pharmaceuticals, Inc.NCT07226661
Phase 4
Mechanistic Clinical Trial Evaluating the Role of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5) in the Antidepressant Mechanism of Cognitive Behavioral Therapy for Insomnia (CBT-I)
This is mechanistic clinical trial that evaluates the role of one of the glutamate receptors (mGluR5) in cognitive behavioral therapy for insomnia (CBT-I) as a…
Major Depressive Disorder (MDD)
Estimated
~$10 – $6,250
Stony Brook UniversityNCT07076342